Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 477 of 5804
-
New drug combo aims to fight Hard-to-Treat cancers
Disease control Recruiting nowPhase IIa study of HX009+ IN10018 in combination with or without standard chemotherapy in patients with advanced solid tumours including biliary tract malignancies and malignant melanoma
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to reduce kidney damage in chronic disease
Disease control OngoingThis study is a multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial designed to investigate the efficacy and safety of different doses of sal0120 tablets in patients with CKD.
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for older lymphoma patients: gentler, smarter treatment on the horizon?
Disease control Recruiting nowThe researchers are doing this study to find out if the study treatment is an effective treatment that causes few or mild side effects in people with diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma (HGBCL), or transformed lymphoma. The treatment being tested in …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for rare autoimmune disease: eculizumab trial targets relapses
Disease control OngoingThe primary objective of this study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of Eculizumab in Chinese Adults with Neuromyelitis Optica Spectrum Disorders (NMOSD).
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New diabetes shot shows promise in Late-Stage trial
Disease control OngoingThe main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New transplant strategy aims to stop lymphoma from spreading to the brain
Prevention Recruiting nowA serious consequence of systemic diffuse large B-cell lymphoma (DLBCL) is secondary central nervous system (CNS) relapse, which occurs in approximately 5% of all patients. Many CNS relapses occur within the first year after completion of frontline treatment and are associated wi…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New balloon could save legs from amputation in artery disease trial
Disease control Recruiting nowThis is a Pivotal, Prospective, randomized, two arm, placebo controlled, single-blind, multicenter trial that will be conducted at approximately 80 sites; approx. 50 sites with at least 50% of subjects will be recruited from USA and approx. 30 sites OUS - Europe, Australia and As…
Phase: NA • Sponsor: Concept Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a back drain save brain bleed patients from a lifetime shunt?
Disease control Recruiting nowIntracerebral hemorrhage (ICH) is a debilitating and fatal disease, especially when the hemorrhage is also entering the cerebral ventricles leading to acute hydrocephalus. In these cases, patients need a drainage through external ventricular drains (EVD). In the longer term, pati…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug shows promise for rare spine cancer
Disease control OngoingThis is an open-label, multicenter phase II study to evaluate the safety, efficacy and pharmacokinetic characteristics of BL-B01D1 for Injection in patients with locally advanced or metastatic chordoma.
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
AI tool aims to take the guesswork out of heart failure emergency care
Knowledge-focused ENROLLING_BY_INVITATIONThe primary goal is to build and test a previously developed and validated risk model and clinical decision support tool embedded within the electronic health record to improve risk stratification of emergency department (ED) patients with acute heart failure (AHF).
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Video games as medicine: VR rehab trial aims to boost recovery in young transplant patients
Disease control CompletedThis randomized controlled, single-blind clinical trial investigates whether virtual reality (VR)-assisted, video game-based exercise training, added to a conventional pulmonary physiotherapy and rehabilitation program, improves functional level, respiratory parameters, and physi…
Phase: NA • Sponsor: Istinye University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Dual-Action pill tame the tumor behind cushing disease?
Disease control Recruiting nowSupported by the pre-clinical data (summarized in Research Strategy), the investigators propose that Fimepinostat is an ideal candidate drug in the treatment and intervention of patients with Cushing Disease. The investigators propose a pilot, short-term (4 weeks) phase II single…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
Disease control Recruiting nowThis phase II trial tests how well cabozantinib in combination with pembrolizumab works in treating patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), that has spread from where it first started (primary site) to other places i…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New vaccine aims to shield kids from hand, foot, and mouth disease
⭐️ VACCINE ⭐️ CompletedThe trial aims to assess the tolerability, safety, and immunogenicity of the tetravalent inactivated enterovirus vaccine in adults and children aged 6 months to 12 years. The main questions it aims to answer are: * Phase Ⅰ: The safety of the investigational vaccine in the target…
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
New hope for lung cancer patients: immunotherapy after surgery may keep cancer away
Disease control Recruiting nowADOPT-lung is an international, multicentre, open-label randomised phase III trial. Protocol treatment consists of 3-4 cycles of neoadjuvant durvalumab in combination with platinum-based doublet chemotherapy, followed by surgery. Patients with R0 and R1 only resection will be ran…
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New 15-Strain HPV vaccine trial aims to broaden cancer protection
⭐️ VACCINE ⭐️ Recruiting nowTo evaluate the safety and Immunogenicity of 15-valent HPV vaccine in 9-45year-old participants.
Phase: PHASE2 • Sponsor: Shanghai Bovax Biotechnology Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:04 UTC
-
New blood test could revolutionize colon cancer staging before surgery
Diagnosis Recruiting nowRecent studies have highlighted the potential benefits of neoadjuvant chemotherapy (NAC) in colon cancer; however, its indication is generally limited to cases corresponding to pathological stage IIB or higher. Accurately identifying such high-risk cases before surgery remains ch…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Could a Fasting-Mimicking diet boost immunotherapy and vitamin c against tough colorectal cancer?
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination with a fasting mimicking diet and high dose vitamin C in treating patients with KRAS-mutant metastatic colorectal cancer. Botensilimab and balstilimab are monoclo…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
5-Day brain zapping trial aims to lift severe depression
Symptom relief Recruiting nowThe CoMPACT trial is a randomized double-blinded sham-controlled study aimed at testing a novel accelerated and personalized transcranial Magnetic Stimulation (TMS) treatment for patients with Treatment Resistant Depression (TRD). CoMPACT consists of 25 sessions of intermittent …
Phase: NA • Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New combo technique may spot lung cancer earlier and more accurately
Diagnosis Recruiting nowThis study is a multicenter study. It plans to screen 200 patients with pulmonary nodule lesions with ground glass as the main body, take CT thin-layer scanning 3D reconstruction, apply AI and fragment omics technology to evaluate the risk of malignant transformation of pulmonary…
Phase: NA • Sponsor: Beidahuang Industry Group General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC